Drug targets identified through cell line to potentially treat rare pediatric cancer

A team of investigators at the Cumming School of Medicine have made key new findings about an extremely rare childhood cancer called neurocutaneous melanocytosis (NCM).

Read more here: http://medicalxpress.com/news/2015-01-drug-cell-line-potentially-rare.html